Sinopharm (国医控股) Placement - Unattractive but Inexpensive

460 Views16 Jan 2020 22:48

Sinopharm Group Co H (1099 HK) is looking to raise about US$539m in its placement. Overall, the deal scores negatively on our framework owing to...

SUMMARY

(Sign Up to Access)

Get started on the Smartkarma Research Network with a complimentary Preview Pass to:

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 3-minute read)

Discussions

(Paid Plans Only)

APAC IPOs & Placements

Insight Stream